Masato Yabuki

577 total citations
15 papers, 294 citations indexed

About

Masato Yabuki is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Masato Yabuki has authored 15 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Masato Yabuki's work include Cell death mechanisms and regulation (7 papers), Synthesis and biological activity (4 papers) and Cancer-related Molecular Pathways (3 papers). Masato Yabuki is often cited by papers focused on Cell death mechanisms and regulation (7 papers), Synthesis and biological activity (4 papers) and Cancer-related Molecular Pathways (3 papers). Masato Yabuki collaborates with scholars based in Japan and United States. Masato Yabuki's co-authors include Masuo Obinata, Shuntaro Ikawa, Ryuhei Okuyama, Tomoyasu Ishikawa, Sei Yoshida, Eisaku Ogawa, Masanori Okaniwa, Setsuya Aiba, Terufumi Takagi and Hachiro Tagami and has published in prestigious journals such as PLoS ONE, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Masato Yabuki

15 papers receiving 286 citations

Peers

Countries citing papers authored by Masato Yabuki

Since Specialization

Citations

This map shows the geographic impact of Masato Yabuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masato Yabuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masato Yabuki more than expected).

Fields of papers citing papers by Masato Yabuki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masato Yabuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masato Yabuki. The network helps show where Masato Yabuki may publish in the future.

Co-authorship network of co-authors of Masato Yabuki

This figure shows the co-authorship network connecting the top 25 collaborators of Masato Yabuki. A scholar is included among the top collaborators of Masato Yabuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masato Yabuki. Masato Yabuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Gene Signature–Based Approach Identified MEK1/2 as a Potential Target Associated With Relapse After Anti-TNFα Treatment for Crohn’s Disease 2018 ·Inflammatory Bowel Diseases ·Kanae Gamo, Yuumi Okuzono, Masato Yabuki, Takashi Ochi, (unknown), Yosuke Sato, (unknown), Hiroki Hayashi, (unknown), Yutaka Nishimoto, (unknown), Zenyu Shiokawa, (unknown), Takahiro Miyazaki, Yukihiko Ebisuno	5
2	Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy 2017 ·PLoS ONE ·Akira Shibata, Masako Kuno, Ryutaro Adachi, Yosuke Sato, (unknown), Atsushi Matsuda, Yuumi Okuzono, (unknown), Yusuke Tominari, Terufumi Takagi, Masato Yabuki, Masanori Okaniwa	14
3	An inhibitor of apoptosis protein antagonist T-3256336 potentiates the antitumor efficacy of the Nedd8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) 2016 ·Biochemical and Biophysical Research Communications ·Hiroyuki Sumi, Masakazu Inazuka, Megumi Morimoto, (unknown), Kentaro Hashimoto, Tomoyasu Ishikawa, Keisuke Kuida, Peter G. Smith, Sei Yoshida, Masato Yabuki	9
4	T-3256336, a novel and orally available small molecule IAP antagonist, induced tumor cell death via induction of systemic TNF alpha production 2016 ·Biochemical and Biophysical Research Communications ·Hiroyuki Sumi, Masakazu Inazuka, Kentaro Hashimoto, Tomoyasu Ishikawa, Sei Yoshida, Masato Yabuki	2
5	Design, stereoselective synthesis, and biological evaluation of novel tri-cyclic compounds as inhibitor of apoptosis proteins (IAP) antagonists 2013 ·Bioorganic & Medicinal Chemistry ·(unknown), Kentaro Hashimoto, Bunnai Saito, Zenyu Shiokawa, Hiroyuki Sumi, Masato Yabuki, (unknown), Kazunobu Aoyama, Teruki Hamada, (unknown), Douglas R. Dougan, Clifford D. Mol, Sei Yoshida, Tomoyasu Ishikawa	11
6	Design, synthesis, and biological activities of novel hexahydropyrazino[1,2-a]indole derivatives as potent inhibitors of apoptosis (IAP) proteins antagonists with improved membrane permeability across MDR1 expressing cells 2013 ·Bioorganic & Medicinal Chemistry ·Zenyu Shiokawa, Kentaro Hashimoto, Bunnai Saito, Yuya Oguro, Hiroyuki Sumi, Masato Yabuki, (unknown), Yohei Kosugi, (unknown), (unknown), Douglas R. Dougan, G. Snell, Sei Yoshida, Tomoyasu Ishikawa	16
7	Discovery of a Selective Kinase Inhibitor (TAK-632) Targeting Pan-RAF Inhibition: Design, Synthesis, and Biological Evaluation of C-7-Substituted 1,3-Benzothiazole Derivatives 2013 ·Journal of Medicinal Chemistry ·Masanori Okaniwa, Masaaki Hirose, Takeo Arita, Masato Yabuki, Akito Nakamura, Terufumi Takagi, Tomohiro Kawamoto, Noriko Uchiyama, (unknown), Shunichirou Tsutsumi, (unknown), Yoshitaka Inui, Bi‐Ching Sang, Jason K. Yano, Kathleen Aertgeerts, Sei Yoshida, Tomoyasu Ishikawa	90
8	Abstract C255: Discovery of TAK-632: A selective kinase inhibitor of pan-RAF with potent antitumor activity against BRAF and NRAS mutant melanomas. 2013 ·Molecular Cancer Therapeutics ·Masanori Okaniwa, Masaaki Hirose, Takeo Arita, Masato Yabuki, Akito Nakamura, Terufumi Takagi, Tomohiro Kawamoto, Noriko Uchiyama, (unknown), Shunichirou Tsutsumi, (unknown), Yoshitaka Inui, Bi‐Ching Sang, Jason K. Yano, Kathleen Aertgeerts, Sei Yoshida, Tomoyasu Ishikawa	1
9	Antitumor Activity and Pharmacodynamic Biomarkers of a Novel and Orally Available Small-Molecule Antagonist of Inhibitor of Apoptosis Proteins 2012 ·Molecular Cancer Therapeutics ·Hiroyuki Sumi, Masato Yabuki, Kenichi Iwai, Megumi Morimoto, (unknown), Masakazu Inazuka, Kentaro Hashimoto, Yohei Kosugi, Kazunobu Aoyama, S. Yamamoto, (unknown), Hideki Yamasaki, Ryuichi Tozawa, Tomoyasu Ishikawa, Sei Yoshida	12
10	Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 2. Synthesis and characterization of a novel imide-type prodrug for improving oral absorption 2012 ·Bioorganic & Medicinal Chemistry ·Masanori Okaniwa, Takashi Imada, Tomohiro Ohashi, T. Miyazaki, Takeo Arita, Masato Yabuki, (unknown), Shunichirou Tsutsumi, (unknown), Terufumi Takagi, Tomohiro Kawamoto, Yoshitaka Inui, Sei Yoshida, Tomoyasu Ishikawa	8
11	Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 3. Evaluation of 5-amino-linked thiazolo[5,4-d]pyrimidine and thiazolo[5,4-b]pyridine derivatives 2012 ·Bioorganic & Medicinal Chemistry ·Masaaki Hirose, Masanori Okaniwa, T. Miyazaki, Takashi Imada, Tomohiro Ohashi, Yuta Tanaka, Takeo Arita, Masato Yabuki, Tomohiro Kawamoto, Shunichirou Tsutsumi, (unknown), Terufumi Takagi, Bi‐Ching Sang, Jason K. Yano, Kathleen Aertgeerts, Sei Yoshida, Tomoyasu Ishikawa	12
12	p51/p63 inhibits ultraviolet B-induced apoptosis via Akt activation 2007 ·Oncogene ·Eisaku Ogawa, Ryuhei Okuyama, Shuntaro Ikawa, (unknown), (unknown), (unknown), Masato Yabuki, Hachiro Tagami, Masuo Obinata, Setsuya Aiba	19
13	p53 homologue, p51/p63, maintains the immaturity of keratinocyte stem cells by inhibiting Notch1 activity 2007 ·Oncogene ·Ryuhei Okuyama, Eisaku Ogawa, (unknown), Masato Yabuki, (unknown), Tadashi Terui, Setsuya Aiba, Masuo Obinata, Hachiro Tagami, Shuntaro Ikawa	61
14	Ser⁴⁶ phosphorylation of p53 is not always sufficient to induce apoptosis: multiple mechanisms of regulation of p53‐dependent apoptosis 2007 ·Genes to Cells ·(unknown), (unknown), Masato Yabuki, Ryuhei Okuyama, Masuo Obinata, Shuntaro Ikawa	22
15	X-irradiation enhances the expression of Bcl-2 in HL-60 cells: the resulting effects on apoptosis and radiosensitivity. 1999 ·International Journal of Molecular Medicine ·(unknown), Yasuhiro Ogawa, Shoji Yōshida, Masato Yabuki, Yoshinari Imajo, Kazuhiko R. Utsumi	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact